{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T17:29:37Z","timestamp":1778261377572,"version":"3.51.4"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"am","delay-in-days":361,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ijantimicag.2020.106083","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T11:36:48Z","timestamp":1594381008000},"page":"106083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Voriconazole topical cream formulation: evidence for stability and antifungal activity"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7850-4239","authenticated-orcid":false,"given":"Camille","family":"Bouchand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe-Henri","family":"Secretan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Guery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Auvity","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremie F.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanny","family":"Lanternier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Cisternino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4443-8843","authenticated-orcid":false,"given":"Jo\u00ebl","family":"Schlatter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2020.106083_bib0001","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/00003495-200767020-00009","article-title":"a review of its use in the management of invasive fungal infections","volume":"67","author":"Scott","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2020.106083_bib0002","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s40262-015-0297-8","article-title":"Therapeutic drug monitoring of voriconazole in the management of invasive fungal infections: A critical review","volume":"54","author":"Elewa","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2020.106083_bib0003","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1517\/14656566.6.7.1215","article-title":"Voriconazole: review of a broad spectrum triazole antifungal agent","volume":"6","author":"Kofla","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ijantimicag.2020.106083_bib0004","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0149-2918(03)80126-1","article-title":"Voriconazole","volume":"25","author":"Jeu","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijantimicag.2020.106083_bib0005","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1186\/s12879-017-2913-8","article-title":"Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections","volume":"17","author":"Xing","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106083_bib0006","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.mycmed.2018.03.009","article-title":"Successful treatment of a recurrent Aspergillus niger otomycosis with local application of voriconazole","volume":"28","author":"Chappe","year":"2018","journal-title":"J Mycol Med"},{"key":"10.1016\/j.ijantimicag.2020.106083_bib0007","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1515\/folmed-2017-0051","article-title":"Microemulgel of voriconazole: an unfathomable protection to counter fungal contagiousness","volume":"59","author":"Ashara","year":"2017","journal-title":"Folia Med (Plovdiv)"},{"key":"10.1016\/j.ijantimicag.2020.106083_bib0008","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/chromsci\/47.7.594","article-title":"Development and validation of a stability-indicating HPLC method for determination of voriconazole and its related substances","volume":"47","author":"Gu","year":"2009","journal-title":"J Chromatogr Sci"},{"key":"10.1016\/j.ijantimicag.2020.106083_bib0009","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/0091270008327537","article-title":"CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole","volume":"49","author":"Weiss","year":"2009","journal-title":"J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.ijantimicag.2020.106083_bib0010","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1128\/AAC.00286-10","article-title":"International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole","volume":"54","author":"Lortholary","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.ijantimicag.2020.106083_bib0011","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/1469-0691.12409","article-title":"Improvement in the outcome of invasive fusariosis in the last decade","volume":"20","author":"Nucci","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 3","key":"10.1016\/j.ijantimicag.2020.106083_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12569","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.ijantimicag.2020.106083_bib0013","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijantimicag.2017.06.017","article-title":"Current antifungal treatment of fusariosis","volume":"51","author":"Al-Hatmi","year":"2018","journal-title":"Int J Antimicrob Agents"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920302533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920302533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:38:27Z","timestamp":1760377107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857920302533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0924857920302533"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106083","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Voriconazole topical cream formulation: evidence for stability and antifungal activity","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106083"}}